The Russian Expert Council on the application of new highly selective inhibitor of Bruton’s tyrosine kinase zanubrutinib in the treatment of patients with relapsed/refractory mantle cell lymphoma. Event review

Autor:	Kamil D. Kaplanov
Jazyk:	ruština
Rok vydání:	2021
Předmět:	mantle cell lymphoma bruton’s tyrosine kinase inhibitor zanubrutinib Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Современная онкология, Vol 23, Iss 2, Pp 253-255 (2021)
Druh dokumentu:	article
ISSN:	1815-1434 1815-1442 18151434
DOI:	10.26442/18151434.2021.2.200936
Popis:	The meeting of the expert council concerning the application of new highly selective inhibitor of Brutons tyrosine kinase zanubrutinib in the treatment of patients with relapsed/refractory mantle cell lymphoma was held in Moscow on April 21, 2021. The leading Russian experts in the field of oncohematology took part in the meeting.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/51e15491eb424cc3a2503cf65691ad49 Zobrazit plný text záznamu View record in DOAJ